AVIDITY BIOSCIENCES

avidity-biosciences-logo

Avidity Biosciences, Inc. is pioneering a new class of oligonucleotide-based therapies called AOCs designed to overcome the current limitations of oligonucleotide therapies in order to treat a wide range of serious diseases. Avidity utilizes its proprietary AOC platform to design, engineer and develop therapeutics that combine the tissue selectivity of monoclonal antibodies and the precision of oligonucleotide therapies in order to access previously undruggable tissue and cell types and more eff... ectively target underlying genetic drivers of diseases. Avidity's lead product candidate, AOC 1001, is designed to treat myotonic dystrophy type 1, and its four other muscle programs are focused on the treatment of muscle atrophy, Duchenne muscular dystrophy, facioscapulohumeral muscular dystrophy and Pompe disease. In addition to its muscle franchise, Avidity has development efforts focused on immune and other cell types.

#SimilarOrganizations #People #Financial #Event #Website #More

AVIDITY BIOSCIENCES

Social Links:

Industry:
Biotechnology Life Science Pharmaceutical

Founded:
2013-01-01

Address:
La Jolla, California, United States

Country:
United States

Website Url:
http://www.aviditybiosciences.com

Total Employee:
11+

Status:
Active

Total Funding:
140.07 M USD


Similar Organizations

arcellx-logo

Arcellx

Arcellx is a clinical-stage biotechnology company that provides patients with superior immune cell therapies.

aura-biosciences-logo

Aura Biosciences

Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.

axcella-logo

Axcella

Axcella is a biotechnology company providing therapeutics development solutions.

nutcracker-therapeutics-logo

Nutcracker Therapeutics

Nutcracker Therapeutics is a biotech company that develops mRNA therapeutics.

syros-pharmaceuticals-logo

Syros Pharmaceuticals

Syros Pharmaceuticals is a life sciences company that focuses on treating diseases by mapping gene regulatory circuits.

vigil-neuroscience-logo

Vigil Neuroscience

Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.


Current Advisors List

troy-wilson_image

Troy Wilson Chairman Of The Board Of Directors @ Avidity Biosciences
Board_member
2012-01-01

jean-kim_image

Jean Kim Board Member @ Avidity Biosciences
Board_member
2021-01-01

Current Employees Featured

frank-mccormick_image

Frank McCormick
Frank McCormick Co-Founder @ Avidity Biosciences
Co-Founder
2012-12-01

steve-hughes_image

Steve Hughes
Steve Hughes Chief Medical Officer @ Avidity Biosciences
Chief Medical Officer
2022-02-01

sarah-boyce_image

Sarah Boyce
Sarah Boyce President & CEO @ Avidity Biosciences
President & CEO
2019-10-01

andrew-geall_image

Andrew Geall
Andrew Geall Vice President of Formulations and Chemistry @ Avidity Biosciences
Vice President of Formulations and Chemistry
2015-01-01

michael-maclean_image

Michael MacLean
Michael MacLean Chief Financial Officer @ Avidity Biosciences
Chief Financial Officer
2020-05-01

arthur-levin_image

Arthur Levin
Arthur Levin Executive Vice President, Research and Development @ Avidity Biosciences
Executive Vice President, Research and Development
2014-01-01

Founder


frank-mccormick_image

Frank McCormick

p-kent-hawryluk_image

P. Kent Hawryluk

troy-wilson_image

Troy Wilson

Stock Details


Company's stock symbol is NASDAQ:RNA

Investors List

perceptive-advisors_image

Perceptive Advisors

Perceptive Advisors investment in Series C - Avidity Biosciences

takeda-ventures_image

Takeda Ventures

Takeda Ventures investment in Series C - Avidity Biosciences

eli-lilly_image

Eli Lilly

Eli Lilly investment in Series C - Avidity Biosciences

logos-capital_image

Logos Capital

Logos Capital investment in Series C - Avidity Biosciences

partner-fund-management_image

Partner Fund Management

Partner Fund Management investment in Series C - Avidity Biosciences

cureduchenne-ventures_image

CureDuchenne Ventures

CureDuchenne Ventures investment in Series C - Avidity Biosciences

rtw-investments-llc_image

RTW Investments LLC

RTW Investments LLC investment in Series C - Avidity Biosciences

cormorant-asset-management_image

Cormorant Asset Management

Cormorant Asset Management investment in Series C - Avidity Biosciences

brace-pharma_image

Brace Pharma

Brace Pharma investment in Series C - Avidity Biosciences

alethea-capital-management_image

Alethea Capital Management

Alethea Capital Management investment in Series C - Avidity Biosciences

Official Site Inspections

http://www.aviditybiosciences.com Semrush global rank: 2.09 M Semrush visits lastest month: 9.87 K

  • Host name: 129.177.197.104.bc.googleusercontent.com
  • IP address: 104.197.177.129
  • Location: United States
  • Latitude: 38.6583
  • Longitude: -77.2481
  • Timezone: America/New_York

Loading ...

More informations about "Avidity Biosciences" on Search Engine